GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IR-Med IRME · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2024

Net income

−$1.9m

FY2020FY2024

Free cash flow

−$1.4m

FY2020FY2024

Shareholders' equity

−$294,000

FY2020FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020
Research and development$1.2m$2.1m$1.9m$1.4m$409,000
Operating income−$1.9m−$4.9m−$4.8m−$3.7m−$730,000
Net income−$1.9m−$4.9m−$4.7m−$3.7m−$752,000
Diluted earnings per share-0.03-0.07-0.07-0.06-0.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020
Total assets$251,000$999,000$3.3m$2.9m$2.1m
Total liabilities$545,000$634,000$702,000$572,000$689,000
Debt—$161,000—$177,000$166,000
Shareholders' equity−$294,000$365,000$2.6m$2.4m$1.4m
Shares outstanding71m70m69m65m65m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020
Cash from operations−$1.4m−$3.2m−$3.4m−$2.5m−$402,000
Capital spending—−$2,000−$50,000−$31,000−$31,000
Free cash flow−$1.4m−$3.2m−$3.4m−$2.5m−$433,000

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Operating income−$286,000−$253,000−$324,000−$601,000−$358,000−$658,000−$1.3m−$1.2m
Net income−$701,000−$773,000−$278,000−$598,000−$366,000−$657,000−$1.3m−$1.2m
Diluted earnings per share-0.01-0.01-0.00-0.01-0.01-0.01-0.02-0.02
Total assets$175,000$124,000$251,000$533,000$887,000$579,000$999,000$1.8m
Debt———$155,000$157,000$160,000$161,000—
Shareholders' equity−$625,000−$493,000−$294,000$2,000$363,000−$86,000$365,000$1.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-19.2%——
Net income-20.1%——

Valuation history

At each fiscal year end

FY2024FY2023
Price to earnings-0.1-0.0

Share price return

Finished calendar years

20252024202320222021
Return-59%100%745%-50%172%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 26 Feb 2020
  • 4-to-1 reverse split · 20 Mar 2013
  • 16000-to-1 reverse split · 10 Dec 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.